MDM2 and MDMX can interact differently with ARF and members of the p53 family

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · see citing works

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · see citing works

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C. J., Sharpe, A. H., Caput, D., Crum, C. P., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,224 · see citing works

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works

p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities

Yang, A., Kaghad, M., Wang, Y., Gillett, E. S., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,086 · see citing works

Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53

Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042 · see citing works

p63 is a p53 homologue required for limb and epidermal morphogenesis

Mills, A. A., Zheng, B., Wang, X., Vogel, H. S., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,974 · see citing works

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works

Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage

Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797 · see citing works

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,630 · see citing works

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

Yang, A., Walker, N., Bronson, R. T., Kaghad, M., Oosterwegel, M. A., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A. H., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 989 · see citing works

Nucleolar Arf sequesters Mdm2 and activates p53

Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940 · see citing works

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Gong, J., Costanzo, A., Yang, H., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 923 · see citing works

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724 · see citing works

Tumor surveillance via the ARF–p53 pathwayPreprint

Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 716 · see citing works

Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC Syndrome

Celli, J., Duijf, P. H. G., Hamel, B. C. J., Bamshad, M. J., Kramer, B., Smits, A., Newbury-Ecob, R. A., Hennekam, R. C. M., Buggenhout, G. V., van Haeringen, A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81646-3 · Cited by 707 · see citing works

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works

MDM2 — master regulator of the p53 tumor suppressor protein

Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · see citing works

Signaling to p53

Prives, C. (1998) · Cell · doi:10.1016/s0092-8674(00)81774-2 · Cited by 623 · see citing works

Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610 · see citing works

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S. M., Weichselbaum, R. W., & Kufe, D. W. (1999) · Nature · doi:10.1038/21704 · Cited by 574 · see citing works

Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 544 · see citing works

P19 ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6937 · Cited by 539 · see citing works

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-839 · Cited by 529 · see citing works

Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

Freedman, D. A., & Levine, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7288 · Cited by 513 · see citing works

Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity

Laurenzi, V. D., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico‐Petruzzelli, M., Levrero, M., & Melino, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1763 · Cited by 366 · see citing works

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355 · see citing works

MDM2 suppresses p73 function without promoting p73 degradation

Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334 · see citing works

MDM2 interacts with MDMX through their RING finger domains

Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324 · see citing works

Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein

Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works

A new human p53 homologue

Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J., & Sidransky, D. (1998) · Nature Medicine · doi:10.1038/nm0798-747 · Cited by 238 · see citing works

Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.

Poon, R. Y. C., Toyoshima, H., & Hunter, T. R. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.9.1197 · Cited by 230 · see citing works

Mdm2 binds p73α without targeting degradation

Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212 · see citing works

MdmX Protects p53 from Mdm2-Mediated Degradation

Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · see citing works

Regulation of Mdm2-Directed Degradation by the C Terminus of p53

Kubbutat, M. H. G., Ludwig, R. L., Ashcroft, M. A., & Vousden, K. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5690 · Cited by 193 · see citing works

Comparative study of the p53-mdm2 and p53-MDMX interfaces

Böttger, V., Böttger, A., Garcia-Echeverria, C., Ramos, Y. F., van der Eb, A. J., Jochemsen, A. G., & Lane, D. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202281 · Cited by 189 · see citing works

Cyclin-dependent Kinases Are Inactivated by a Combination of p21 and Thr-14/Tyr-15 Phosphorylation after UV-induced DNA Damage

Poon, R. Y. C., Jiang, W. B., Toyoshima, H., & Hunter, T. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13283 · Cited by 171 · see citing works

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

Dobbelstein, M., Wienzek, S., König, C., & Roth, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202512 · Cited by 161 · see citing works

Isolation and Identification of the Human Homolog of a New p53-Binding Protein, Mdmx

Shvarts, A., Bazuine, M., Dekker, P., Ramos, Y. F., Steegenga, W. T., Merckx, G., van Ham, R. C. A., van Oordt, C. W. M. D. H., van der Eb, A. J., & Jochemsen, A. G. (1997) · Genomics · doi:10.1006/geno.1997.4775 · Cited by 152 · see citing works

An Inhibitor of Nuclear Export Activates the p53 Response and Induces the Localization of HDM2 and p53 to U1A-Positive Nuclear Bodies Associated with the PODs

Laı́n, S., Midgley, C., Sparks, A., Lane, E. B., & Lane, D. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4433 · Cited by 135 · see citing works

MDM2 and MDMX bind and stabilize the p53-related protein p73

Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W. S., Yamashita, K., Harris, A. L., Cox, L. S., & Poon, R. Y. C. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80367-4 · Cited by 132 · see citing works

MDM2-arbiter of p53's destruction

Lane, D. P., & Hall, P. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01119-5 · Cited by 126 · see citing works

A Novel MDMX Transcript Expressed in a Variety of Transformed Cell Lines Encodes a Truncated Protein with Potent p53 Repressive Activity

Rallapalli, R., Strachan, G. D., Cho, B., Mercer, W. E., & Hall, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8299 · Cited by 113 · see citing works

Regulation of Cyclin A-Cdk2 by SCF Component Skp1 and F-Box Protein Skp2

Yam, C. H., Ng, R. W. M., Siu, W. Y., Lau, A. W. S., & Poon, R. Y. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.635 · Cited by 81 · see citing works

Comparative Analysis of P73 and P53 Regulation and Effector Functions

Li, F., Lee, S. W., & Aaronson, S. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.4.823 · Cited by 75 · see citing works

Isolation and Characterization of TAF25, an Essential Yeast Gene That Encodes an RNA Polymerase II-specific TATA-binding Protein-associated Factor

Klebanow, E. R., Poon, D., Zhou, S., & Weil, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13706 · Cited by 62 · see citing works

MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.

Yam, C. H., Siu, W. Y., Arooz, T., Chiu, C. H. S., Lau, A. W. S., Wang, X. Q., & Poon, R. Y. C. (1999) · PubMed · Cited by 46 · see citing works

Constitutive mdmx Expression During Cell Growth, Differentiation, and DNA Damage

Jackson, M. W., & Berberich, S. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314971 · Cited by 27 · see citing works

Another p53 Doppelgänger?

Kaelin, W. G. (1998) · Science · doi:10.1126/science.281.5373.57 · Cited by 24 · see citing works

The p53–Mdm2 module and the ubiquitin system

Michael, D., & Oren, M. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00099-8 · Cited by 759 · see citing works

p73: Friend or foe in tumorigenesis

Melino, G., Laurenzi, V. D., & Vousden, K. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc861 · Cited by 554 · see citing works

The p53 orchestra: Mdm2 and Mdmx set the tone

Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works

MDMX: from bench to bedside

Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works

p53 family update: p73 and p63 develop their own identities.

Irwin, M. S., & Kaelin, W. G. (2001) · PubMed · Cited by 222 · see citing works

p53-family proteins and their regulators: hubs and spokes in tumor suppression

Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 219 · see citing works

TP53 family members and human cancers

Bénard, J., Douc‐Rasy, S., & Ahomadegbe, J. (2003) · Human Mutation · doi:10.1002/humu.10172 · Cited by 205 · see citing works

A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism

Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 203 · see citing works

Mdmx as an essential regulator of p53 activity

Marine, J., & Jochemsen, A. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.151 · Cited by 186 · see citing works

HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function

Lau, L. M. S., Nugent, J. K., Zhao, X., & Irwin, M. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210707 · Cited by 182 · see citing works

Control of p53 ubiquitination and nuclear export by MDM2 and ARF.

Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176 · see citing works

Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Wade, M., & Wahl, G. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0423 · Cited by 170 · see citing works

How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?

Chan, W. M., Siu, W. Y., Lau, A. W. S., & Poon, R. Y. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3536-3551.2004 · Cited by 159 · see citing works

Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Maerken, T. V., Speleman, F., Vermeulen, J., Lambertz, I., Clercq, S. D., Smet, E. D., Yigit, N., Coppens, V., Philippé, J., Paepe, A. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0792 · Cited by 154 · see citing works

p63 and epithelial biology

Barbieri, C. E., & Pietenpol, J. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.028 · Cited by 140 · see citing works

Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3

LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works

Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function

Watson, I. R., Blanch, A., Lin, D. C. C., Ohh, M., & Irwin, M. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603654200 · Cited by 120 · see citing works

A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis

Wang, H., Ma, X., Ren, S., Buolamwini, J. K., & Yan, C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0581 · Cited by 117 · see citing works

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and <i>MDM2</i> Amplification in Sarcomagenesis

Ito, M., Barys, L., O'Reilly, T., Young, S., Gorbatcheva, B., Monahan, J., Zumstein-Mecker, S., Choong, P. F., Dickinson, I., Crowe, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2050 · Cited by 115 · see citing works

Functional interplay between MDM2, p63/p73 and mutant p53

Stindt, M., Muller, P. A. J., Ludwig, R., Kehrloesser, S., Dötsch, V., & Vousden, K. H. (2014) · Oncogene · doi:10.1038/onc.2014.359 · Cited by 109 · see citing works

Mdm2–p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin

Gannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87 · see citing works

A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation

Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87 · see citing works

Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation

Migliorini, D., Danovi, D., Colombo, E., Carbone, R., Pelicci, P. G., & Marine, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108795200 · Cited by 86 · see citing works

The C-terminus of p63 contains multiple regulatory elements with different functions

Straub, W. E., Weber, T. A., Schäfer, B., Candi, E., Durst, F., Ou, H. D., Rajalingam, K., Melino, G., & Dötsch, V. (2010) · Cell Death and Disease · doi:10.1038/cddis.2009.1 · Cited by 84 · see citing works

MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondPreprint

Marine, J., & Jochemsen, A. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026237 · Cited by 81 · see citing works

The Mdm network and its regulation of p53 activities: a rheostat of cancer risk

Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79 · see citing works

Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases

Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79 · see citing works

Ubiquitin and Ubiquitin-Like Modifications of the p53 Family

Watson, I. R., & Irwin, M. S. (2006) · Neoplasia · doi:10.1593/neo.06439 · Cited by 76 · see citing works

High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53

Klein, C., Georges, G. J., Künkele, K., Huber, R., Engh, R. A., & Hansen, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103801200 · Cited by 71 · see citing works

Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway

Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69 · see citing works

MDM2 Is Required for Suppression of Apoptosis by Activated Akt1 in Salivary Acinar Cells

Limesand, K. H., Schwertfeger, K. L., & Anderson, S. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01846-05 · Cited by 69 · see citing works

Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73

Zdzalik, M., Pustelny, K., Kędracka–Krok, S., Huben, K., Pęcak, A., Władyka, B., Jankowski, S., Dubin, A., Potempa, J., & Dubin, G. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13871 · Cited by 65 · see citing works

Hdmx and Mdm2 can repress transcription activation by p53 but not by p63

Little, N. A., & Jochemsen, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204615 · Cited by 64 · see citing works

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 61 · see citing works

Structural diversity of p63 and p73 isoforms

Osterburg, C., & Dötsch, V. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00975-4 · Cited by 63 · see citing works

Alterations of p63 and p73 in Human Cancers

Inoue, K., & Fry, E. A. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_2 · Cited by 58 · see citing works

Mdm2: A Regulator of Cell Growth and Death

Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57 · see citing works

Binding of 14-3-3β but not 14-3-3σ controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B

Uchida, S., Kuma, A., Ohtsubo, M., Shimura, M., Hirata, M., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01086 · Cited by 55 · see citing works

The evolution of MDM2 family genes

Momand, J. A., Villegas, A., & Белый, В. А. (2011) · Gene · doi:10.1016/j.gene.2011.06.030 · Cited by 55 · see citing works

DNA Damage during the Spindle-Assembly Checkpoint Degrades CDC25A, Inhibits Cyclin–CDC2 Complexes, and Reverses Cells to Interphase

Chow, J. P. H., Siu, W. Y., Fung, T. K., Chan, W. M., Lau, A. W. S., Arooz, T., Ng, C.-P., Yamashita, K., & Poon, R. Y. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0168 · Cited by 51 · see citing works

A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells

Wang, H., & Yan, C. (2011) · Neoplasia · doi:10.1593/neo.11438 · Cited by 49 · see citing works

Pirh2 E3 Ubiquitin Ligase Modulates Keratinocyte Differentiation through p63

Jung, Y.-S., Qian, Y., Yan, W., & Chen, X. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.466 · Cited by 48 · see citing works

The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System

Armstrong, S., Wu, H., Wang, B., Abuetabh, Y., Sergi, C. M., & Leng, R. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122041 · Cited by 48 · see citing works

Differences in the transactivation domains of p53 family members: a computational study

Mavinahalli, J., Madhumalar, A., Beuerman, R. W., Lane, D. P., & Verma, C. S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s1-s5 · Cited by 46 · see citing works

Anatomy of Mdm2 and Mdm4 in evolution

Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40 · see citing works

MDM4 (MDMX) and its Transcript Variants

Mancini, F., Conza, G. D., & Moretti, F. (2009) · Current Genomics · doi:10.2174/138920209787581280 · Cited by 39 · see citing works

MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis

Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311793200 · Cited by 38 · see citing works

MDM2 and MDMX in Cancer and Development

Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 38 · see citing works

Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis

Benosman, S., Groß, I., Clarke, N., Jochemsen, A. G., Okamoto, K., Loeffler, J., & Gaiddon, C. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402216 · Cited by 38 · see citing works

Regulation of p63 Protein Stability via Ubiquitin-Proteasome Pathway

Li, C., & Xiao, Z. J. (2014) · BioMed Research International · doi:10.1155/2014/175721 · Cited by 36 · see citing works

Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma

Reis, A. H. D. O., de Carvalho, I. N. S. R., Damasceno, P. B. D. S., Ferman, S., Lucena, E., López‐Camelo, J. S., Seuánez, H. N., & Vargas, F. R. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24014 · Cited by 33 · see citing works

Abnormal MDMX degradation in tumor cells due to ARF deficiency

Li, X., Gilkes, D., Li, B., Cheng, Q., Pernazza, D., Lawrence, H., Lawrence, N., & Chen, J. (2012) · Oncogene · doi:10.1038/onc.2011.534 · Cited by 32 · see citing works

ING1b decreases cell proliferation through p53‐dependent and ‐independent mechanisms

Tsang, F. C., Po, L. S., Leung, K. M., Lau, A. W. S., Siu, W. Y., & Poon, R. Y. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01024-x · Cited by 32 · see citing works

p73: From the p53 shadow to a major pharmacological target in anticancer therapy

Ramos, H., Raimundo, L., & Saraiva, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105245 · Cited by 31 · see citing works

The flexible evolutionary anchorage-dependent Pardee's restriction point of mammalian cells. How its deregulation may lead to cancer

David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 29 · see citing works

Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis

Tozluoǧlu, M., Karaca, E., Haliloǧlu, T., & Nussinov, R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn481 · Cited by 26 · see citing works

Sempervirine inhibits RNA polymerase I transcription independently from p53 in tumor cells

Caggiano, C., Guida, E., Todaro, F., Bielli, P., Mori, M., Ghirga, F., Quaglio, D., Botta, B., Moretti, F., Grimaldi, P., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00345-4 · Cited by 21 · see citing works

Roles of p63 in Epidermal Development and Tumorigenesis

Yao, J.-Y., & Chen, J. (2012) · Biomedical Journal · doi:10.4103/2319-4170.104410 · Cited by 22 · see citing works

Total ginsenosides of Chinese ginseng induces cell cycle arrest and apoptosis in colorectal carcinoma HT‑29 cells

Li, T., Sun, W., Dong, X., Yu, W., Cai, J., Yuan, Q., Shan, L., & Efferth, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.9192 · Cited by 19 · see citing works

The p53 Isoform Δp53 Lacks Intrinsic Transcriptional Activity and Reveals the Critical Role of Nuclear Import in Dominant-Negative Activity

Chan, W. M., & Poon, R. Y. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3602 · Cited by 18 · see citing works

MDM2 oligomers: antagonizers of the guardian of the genome

Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 17 · see citing works

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing

Zawacka‐Pankau, J. (2020) · Cancers · doi:10.3390/cancers12092717 · Cited by 16 · see citing works

p53 family interactions and yeast: together in anticancer therapy

Gomes, S., Leão, M., Raimundo, L., Ramos, H., Soares, J., & Saraiva, L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.007 · Cited by 16 · see citing works

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

Urso, L., Cavallari, I., Silic‐Benussi, M., Biasini, L., Zago, G., Calabrese, F., Conte, P., Ciminale, V., & Pasello, G. (2017) · Oncotarget · doi:10.18632/oncotarget.17790 · Cited by 15 · see citing works

Studying p53 family proteins in yeast: Induction of autophagic cell death and modulation by interactors and small molecules

Leão, M., Gomes, S., Bessa, C., Soares, J., Raimundo, L., Monti, P., Fronza, G., Pereira, C., & Saraiva, L. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.028 · Cited by 15 · see citing works

Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors

Omran, Z., Dalhat, M. H., Abdullah, O., Kaleem, M., Hosawi, S. B. I., Al-Abbasi, F. A., Wu, W., Choudhry, H., & Alhosin, M. (2021) · Cancers · doi:10.3390/cancers13081916 · Cited by 15 · see citing works

Amino Acids C-Terminal to the 14-3-3 Binding Motif in CDC25B Affect the Efficiency of 14-3-3 Binding

Uchida, S., Kubo, A., Kizu, R., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj079 · Cited by 14 · see citing works

Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells

Sznarkowska, A., Kostecka, A., Kawiak, A., Acedo, P., Lion, M., Inga, A., & Zawacka‐Pankau, J. (2018) · Cell Division · doi:10.1186/s13008-018-0043-3 · Cited by 13 · see citing works

Distinct p63 and p73 Protein Interactions Predict Specific Functions in mRNA Splicing and Polyploidy Control in Epithelia

Rozenberg, J. M., Rogovaya, O. S., Melino, G., Barlev, N. A., & Kagansky, A. (2020) · Cells · doi:10.3390/cells10010025 · Cited by 9 · see citing works

Monoclonal antibodies raised against Xenopus p53 interact with human p73

Bras, M. L., Delattre, V., Bensaad, K., Blandino, G., & Soussi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205189 · Cited by 5 · see citing works

Set the Tone:

(2018) · Yale University Press eBooks · doi:10.2307/j.ctvqc6gvg.12 · Cited by 2 · see citing works

TP63, TP73: The Guardian’s Elder Brothers

Courtois-Cox, S., Hainaut, P. L., & de Fromentel, C. C. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_3 · Cited by 1 · see citing works

p53, p63 and p73 Network in Breast Cancers

Leong, C. (2011) · InTech eBooks · doi:10.5772/20337 · Cited by 1 · see citing works

Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP 53-deficient cancer cellsPreprint

Sznarkowska, A., Kostecka, A., Kawiak, A., Acedo, P., Lion, M., Inga, A., & Zawacka‐Pankau, J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/357293 · Cited by 1 · see citing works

Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation

Latonen, L. (2003) · Työväentutkimus Vuosikirja

Modification of MDMX by Ubiquitination and Sumoylation

Pan, Y. (2005) · Digital Commons - University of South Florida (University of South Florida)

Molecular focus in p63 and correlated human diseases

Hashemi, M., Jamshidian, F., & Shamei, M. H. (2012) · Archives of Advances in Biosciences · doi:10.22037/jps.v3i1.2935

Increased Radioresistance and Accelerated B Cell LymphomasinMicewithMdmxMutationsthatPrevent

Wang, Y. V., Leblanc, M., Wade, M. R., Jochemsen, A. G., & Wahl, G. M. (2009)

Induction of p53 Dependent Cellular Senescence Through HdmX Inhibition or YPEL3 Expression

Miller, K. L. (2010) · Journal of Bioresource Management

Characterization of the Ubiquitin/Nedd8 E3 ligase activity of the Mdm2/MdmX complex

Singh, R. K. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)

The p53 family interacting pathways in carcinogenesis and cellular response to DNA damage

Johnson, J. L. (2007) · doi:10.6083/m42f7kd0

Regulation of the transcription factor p63 by [beta]TrCP

Gallegos, J. R. (2008) · doi:10.6083/m4513w4d

Molecular Mechanisms of p63-Derived Ectodermal Dysplasia

Lustig, D. G. (2012) · TSpace (University of Toronto)

Regulation of MDM2 and the p53 Family by the NEDD8 Pathway

Watson, I. R. (2011) · TSpace (University of Toronto)

Avaliação dos mecanismos moleculares das vias de p53/ARF e IFNbeta envolvidos com a resposta de células de melanoma ao tratamento com os transgenes p19Arf e IFNbeta

Ribeiro, A. H. (2016) · doi:10.11606/t.5.2016.tde-04112016-142136

MDM4 (Murine Double Minute 4)

Huang, A., Yang, E., & Kurokawa, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101575-1

MDM4 (Murine Double Minute 4)

Huang, A., Yang, E., & Kurokawa, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101575

Data from Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Maerken, T. V., Speleman, F., Vermeulen, J., Lambertz, I., Clercq, S. D., Smet, E. D., Yigit, N., Coppens, V., Philippé, J., Paepe, A. D., et al. (2023) · doi:10.1158/0008-5472.c.6494438

Data from Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Maerken, T. V., Speleman, F., Vermeulen, J., Lambertz, I., Clercq, S. D., Smet, E. D., Yigit, N., Coppens, V., Philippé, J., Paepe, A. D., et al. (2023) · doi:10.1158/0008-5472.c.6494438.v1

Data from A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis

Wang, H., Ma, X., Ren, S., Buolamwini, J. K., & Yan, C. (2023) · doi:10.1158/1535-7163.c.6531407

Data from A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis

Wang, H., Ma, X., Ren, S., Buolamwini, J. K., & Yan, C. (2023) · doi:10.1158/1535-7163.c.6531407.v1

N-terminal isoforms of the p53 tumour suppressor protein : effects on p53 transcriptional activity and expression in cutaneous melanoma

Hafsi, H. (2012) · doi:10.70675/636eb035zeb70z452ez8b98z0fdc80a752bb

Mdm2-p53 Signaling in Tissue Homeostasis and the DNA Damage Response: A Dissertation

Gannon, H. (2012) · eScholarship@UMassChan · doi:10.13028/sfjc-xh51

MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation

Jackson, M. W., Lindström, M. S., & Berberich, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010685200 · Cited by 74 · see citing works

The Human MDM2 Oncoprotein Increases the Transcriptional Activity and the Protein Level of the p53 Homolog p63

Calabrò, V., Mansueto, G., Parisi, T., Vivo, M., Calogero, R., & Mantia, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107173200 · Cited by 94 · see citing works

MDM2 promotes ubiquitination and degradation of MDMX

Pan, Y., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5113-5121.2003 · Cited by 246 · see citing works

Inhibition of p63 Transcriptional Activity by p14ARF: Functional and Physical Link between Human ARF Tumor Suppressor and a Member of the p53 Family

Calabrò, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., & Mantia, G. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8529-8540.2004 · Cited by 26 · see citing works

Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73

Zdzalik, M., Pustelny, K., Kędracka–Krok, S., Huben, K., Pęcak, A., Władyka, B., Jankowski, S., Dubin, A., Potempa, J., & Dubin, G. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13871 · Cited by 65 · see citing works